81 related articles for article (PubMed ID: 619932)
1. The disposition of debrisoquine in hypertensive patients.
Silas JH; Lennard MS; Tucker GT; Smith AJ; Malcolm SL; Marten TR
Br J Clin Pharmacol; 1978 Jan; 5(1):27-34. PubMed ID: 619932
[No Abstract] [Full Text] [Related]
2. Why hypertensive patients vary in their response to oral debrisoquine.
Silas JH; Lennard MS; Tucker GT; Smith AJ; Malcolm SL; Marten TR
Br Med J; 1977 Feb; 1(6058):422-5. PubMed ID: 837136
[TBL] [Abstract][Full Text] [Related]
3. Hypotensive response to debrisoquine and hydroxylation phenotype.
Idle JR; Mahgoub A; Lancaster R; Smith RL
Life Sci; 1978 Mar; 22(11):979-83. PubMed ID: 642709
[No Abstract] [Full Text] [Related]
4. Polymorphic hydroxylation of debrisoquine.
Tucker GT; Silas JH; Iyun AO; Lennard MS; Smith AJ
Lancet; 1977 Oct; 2(8040):718. PubMed ID: 71525
[No Abstract] [Full Text] [Related]
5. Extremely rapid hydroxylation of debrisoquine: a case report with implication for treatment with nortriptyline and other tricyclic antidepressants.
Bertilsson L; Aberg-Wistedt A; Gustafsson LL; Nordin C
Ther Drug Monit; 1985; 7(4):478-80. PubMed ID: 4082245
[No Abstract] [Full Text] [Related]
6. Lack of relationship between debrisoquine oxidation phenotype and the pharmacokinetics and first dose effect of prazosin.
Lennard MS; McGourty JC; Silas JH
Br J Clin Pharmacol; 1988 Feb; 25(2):276-8. PubMed ID: 3358891
[TBL] [Abstract][Full Text] [Related]
7. [Antihypertensive action of debrisoquine (author's transl)].
Perret L
Schweiz Rundsch Med Prax; 1975 May; 64(21):653-9. PubMed ID: 1096131
[No Abstract] [Full Text] [Related]
8. Polymorphic 4-hydroxylation of debrisoquine in chronic discoid psoriasis.
Chapman PH; Rawlins MD; Shuster S; Idle JR; Ritchie JC; Smith RL
Eur J Clin Pharmacol; 1981; 21(3):257-8. PubMed ID: 6895622
[No Abstract] [Full Text] [Related]
9. [Treatment of hypertension with the preparation Tendor].
Stanchev A; Shishmanova Iu; Sheĭtanov I; Georgiev I
Vutr Boles; 1977; 16(6):34-8. PubMed ID: 341531
[TBL] [Abstract][Full Text] [Related]
10. [Clinical follow-up of a group of hypertensive patients during the year after finishing a therapeutic study with a new hypotensive drug].
Ocon Pujadas J
Rev Clin Esp; 1973 Feb; 128(4):331-6. PubMed ID: 4700584
[No Abstract] [Full Text] [Related]
11. [Therapeutic results with the hypotensive agent Declinax (debrisoquin) in mild and medium forms of hypertension].
Bückert A; Schweda E; Vich V
Schweiz Rundsch Med Prax; 1973 Nov; 62(47):1453-60. PubMed ID: 4202234
[No Abstract] [Full Text] [Related]
12. Clinical trials with Tendor (debrisoquine sulfate).
Langer L; Gerö A
Ther Hung; 1974; 22(4):165-71. PubMed ID: 4465961
[No Abstract] [Full Text] [Related]
13. Proceedings: A correlation between the response to debrisoquine and the amount of unchanged drug excreted in the urine.
Angelo M; Dring LG; Lancaster R; Latham A; Smith RL
Br J Pharmacol; 1975 Oct; 55(2):264P. PubMed ID: 1201404
[No Abstract] [Full Text] [Related]
14. The management of hypertension with special reference to debrisoquine and beta blockade.
Turner R; White P; Benton F
Practitioner; 1976 Apr; 216(1294):431. PubMed ID: 5718
[No Abstract] [Full Text] [Related]
15. Comparison of debrisoquine and guanethidine in treatment of hypertension.
Adi FC; Eze CJ; Anwunah A
Br Med J; 1975 Mar; 1(5956):482-5. PubMed ID: 1125586
[TBL] [Abstract][Full Text] [Related]
16. The metabolism of [14C]-debrisoquine in man.
Idle JR; Mahgoub A; Angelo MM; Dring LG; Lancaster R; Smith RL
Br J Clin Pharmacol; 1979 Mar; 7(3):257-66. PubMed ID: 371651
[TBL] [Abstract][Full Text] [Related]
17. Effect of cirrhosis and debrisoquin phenotype on the disposition and effects of pinacidil.
Shaheen O; Patel J; Avant GR; Hamilton M; Wood AJ
Clin Pharmacol Ther; 1986 Dec; 40(6):650-5. PubMed ID: 3780126
[TBL] [Abstract][Full Text] [Related]
18. An evaluation of debrisoquine and mefruside in the treatment of hypertension in African and Indian patients.
Seedat YK
Curr Med Res Opin; 1980; 7(1):68-72. PubMed ID: 7428417
[TBL] [Abstract][Full Text] [Related]
19. Tolerance and side effects during long term treatment of hypertension with debrisoquine.
Jackson WB
Aust N Z J Med; 1972 Nov; 2(4):357-65. PubMed ID: 4144623
[No Abstract] [Full Text] [Related]
20. [Evaluation by practicing physicians of the antihypertensive efficacy of debrisoquin, methyldopa and propranolol].
Avigdor L; Waeber B; Brunner HR
Schweiz Med Wochenschr; 1983 Mar; 113(9):331-8. PubMed ID: 6342133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
